MYRIAD GENETICS (MYD.SG) (MYD STU) stock market data APIs
€4.4811
0.01(0.2%)
as of June 27, 2025
Try our APIs with
free plan!
MYRIAD GENETICS (MYD.SG) Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for MYD.SG.
Prev. Close
4.4811
Open
4.4957
High
4.4957
Low
4.4811
52 wk Range
3.4-26.2
Market Cap
1 751 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get MYRIAD GENETICS (MYD.SG) data using free add-ons & libraries
Get MYRIAD GENETICS (MYD.SG) Fundamental Data
MYRIAD GENETICS (MYD.SG) Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
MYRIAD GENETICS (MYD.SG) News
New
Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside?
In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market. Accor...
Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing
Myriad Genetics, Inc. Study published in the Journal of Clinical Psychopharmacology SALT LAKE CITY, April 21, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular dia...
Myriad Genetics price target lowered to $9 from $11 at BofA
BofA lowered the firm’s price target on Myriad Genetics (MYGN) to $9 from $11 and keeps an Underperform rating on the shares. Sentiment for Life Sciences and Diagnostic Tools and Contract Research O...
Myriad Genetics Announces Inducement Awards
Myriad Genetics, Inc. SALT LAKE CITY, April 08, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostics testing and precision medicine, announced today that i...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
